CaPSID: A bioinformatics platform for computational pathogen sequence identification in human genomes and transcriptomes by Borozan Ivan et al.
Borozan etal. BMCBioinformatics 2012, 13:206
http://www.biomedcentral.com/1471-2105/13/206
SOFTWARE Open Access
CaPSID: A bioinformatics platform for
computational pathogen sequence
identiﬁcation in human genomes and
transcriptomes
Ivan Borozan1, Shane Wilson1, Paola Blanchette3, Philippe Laﬂamme1,S t u a r tNW a t t 1,
Paul M Krzyzanowski2, Fabrice Sircoulomb2, Robert Rottapel2, Philip E Branton3,4,5 and Vincent Ferretti1*
Abstract
Background: Itisnowwellestablished thatnearly20%ofhumancancersarecausedbyinfectiousagents, andthelist
of human oncogenic pathogens will grow in the future for a variety of cancer types. Whole tumor transcriptome and
genome sequencing by next-generation sequencing technologies presents an unparalleled opportunity for pathogen
detection and discovery in human tissues but requires development of new genome-wide bioinformatics tools.
Results: Here we present CaPSID (Computational Pathogen Sequence IDentiﬁcation), a comprehensive
bioinformatics platform for identifying, querying and visualizing both exogenous and endogenous pathogen
nucleotide sequences in tumor genomes and transcriptomes. CaPSID includes a scalable, high performance database
for data storage and a web application that integrates the genome browser JBrowse. CaPSID also provides useful
metrics for sequence analysis of pre-aligned BAM ﬁles, such as gene and genome coverage, and is optimized to run
eﬃciently on multiprocessor computers with low memory usage.
Conclusions: To demonstrate the usefulness and eﬃciency of CaPSID, we carried out a comprehensive analysis of
both a simulated dataset and transcriptome samples from ovarian cancer. CaPSID correctly identiﬁed all of the human
and pathogen sequences in the simulated dataset, while in the ovarian dataset CaPSID’s predictions were successfully
validated in vitro.
Background
Speciﬁc viruses have been proved to be etiologic agents of
human cancer and cause 15% to 20% of all human tumors
worldwide [1]. Moreover, epidemiological studies indicate
thatnewoncogenicpathogensareyettobediscovered[2].
The International Cancer Genome Consortium (ICGC)
[3], which intends to study 25 000 tumors belonging to 50
diﬀerenttypesofcancerusingnextgenerationsequencing
technologies, will allow for the ﬁrst time an in-depth anal-
ysisoftheviralsequencecontentofthousandsofcomplete
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human tumor genomes and transcriptomes. This repre-
sents a unique opportunity for the identiﬁcation of new
tumor-associated human pathogens.
However, this opportunity can be fully realized only
in conjunction with the development of new genome-
wide bioinformatics tools. In this context, several com-
putational approaches have already been developed and
successfully applied for the discovery and detection of
known and new pathogens in tumor samples [4-9]. We
present here CaPSID, a comprehensive open source plat-
form which integrates fast and memory-eﬃcient com-
putational pipeline for pathogen sequence identiﬁcation
and characterization in human genomes and transcrip-
tomes together with a scalable results database and an
easy-to-useweb-basedsoftwareapplicationformanaging,
querying and visualizing results.
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Implementation
CaPSID implements an improved form of a computa-
tional approach known as “digital subtraction” [10] that
consists of subtracting in silico known human short
read sequences from human transcriptome (or genome)
samples, leaving candidate non-human sequences to be
aligned against known pathogen reference sequences.
CaPSID diﬀers from traditional digital subtraction (e.g.,
[8]),whichisusedasaﬁlter,eliminatinghumansequences
from the dataset before comparison with pathogen ref-
erence sequences. By contrast, CaPSID matches reads
against both human and pathogen reference sequences,
dividing the reads into three disjoint sets per sample: a set
that aligns to pathogen sequences, a set that aligns to both
human and pathogen sequences, and a set that does not
align to either human or pathogen sequences. This three-
way division forms the basis for an exploratory environ-
ment for both known and unknown pathogen research.
As shown in Figure 1, CaPSID consists of three linked
components:
• A pipeline to analyze and maintain sequencing
datasets
• A database which stores reference samples and
analysis results
• An interactive interface to browse, search, and
explore identiﬁed candidate pathogen data
The CaPSID Pipeline
The CaPSID pipeline is a suite of command-line tools
written in Python designed to identify, through digital
subtraction, non-human nucleotide sequences in short
read datasets generated by deep sequencing of RNA or
DNA tumor samples.
The pipeline can be conceptually divided in two distinct
modules. The ﬁrst module, called the Genomes Mod-
ule, provides users with tools to create and update the
in-house reference sequence database required by CaP-
SID for applying the digital subtraction. It uses BioPy-
thon [11] to eﬃciently parse GenBank ﬁles and loads
whole genome reference sequences, as well as some of
their annotations (e.g. gene and CDS locations), into CaP-
SID’s database. Our database contains complete sets of
human (GRCh37/hg19), viral (4015), microbial (bacterial
and archaea) (38035), and fungal (53098) genomes (as of
December 2011) from UCSC [12] and NCBI [13]. This
module also provides the tools to create customized refer-
encesequenceFASTAﬁlesneededbyshortreadsequence
alignment software.
The second module, called the Analysis Module
(see Figure 1), is responsible for executing the digital
subtraction and for analyzing its results. It requires two
BAM ﬁles as input for each sequenced sample to be ana-
lyzed: one containing the short read alignment results to
Figure 1 CaPSID platform. The CaPSID platform is made of three components: A computational pipeline written in Python for executing digital
subtraction, a core MongoDB database for storing reference sequences and alignment results, and a web application in Grails for visualizing and
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the human reference sequences (HRS) and one contain-
ing the alignment results to all the pathogen reference
sequences (PRS) found in the CaPSID database.
CaPSID can directly process BAM ﬁles containing
header lines formatted according to NCBI FASTA speciﬁ-
cation. In order to produce BAM ﬁles that can be loaded
into CaPSID, a user can also export genome reference ﬁles
from CaPSID for passing to the short read aligner. Before
processing the BAM ﬁles, the user can specify a minimum
required MAPQ score and all aligned reads that fall below
that value will be removed from the analysis. CaPSID can
process BAM ﬁles containing either single-end or pair-
end reads and will automatically determine which analysis
method is appropriate. Digital subtraction is not limited
to a human reference sequence and can be executed with
any host organism as long as its reference sequence has
been loaded into the database.
In theory, any short read alignment program - as long
as it produces BAM ﬁles– is suitable for CaPSID. How-
ever, one restriction applies, namely that multiple align-
ment locations for individual reads must be reported
as they can map to more than one pathogen genome.
We selected Novoalign (Novocraft Technologies [14])
for its ﬂexibility (allows both mismatches and gaps),
accuracy and speed. For ABI SOLiD sequencing data,
we chose to use BioScope (Applied Biosystems). Both
of these aligners are commercial programs with costly
licences. However there are freely available and open
source alternatives such as the recently released Bowtie
2 [15] (also allowing both mismatches and gaps) and
SHRiMP2 [16].
As output, CaPSID’s digital subtraction implementation
produces three disjoint sets of short reads (or records) per
sample: a set that aligns to any of the PRS, a set that aligns
to both HRS and PRS and a set of reads that does not
align to any of the reference sequences (both human and
pathogens).
In Algorithm 1 we outline the digital subtraction
method used by CaPSID, and how the three disjoint sets
are constructed. CaPSID uses the pysam Python module
to read and process aligned short read sequences from
two input BAM ﬁles (LHRS and LNHRS are read from the
same BAM ﬁle, in two passes). The algorithm ﬁrst pro-
cesses alignment information for each read that maps to
the PRS and stores it to the CaPSID’s database (lines 1
to 3). Next, the algorithm processes alignment informa-
tion for reads that map to HRS, storing it into CaPSID
if the same read identiﬁer also maps to the PRS (lines 4
to 8). To avoid memory performance problems, LHRS,
which may be very large, is processed sequentially. Finally,
with another pass through the same BAM ﬁle, this time
selecting reads that do not align to the human refer-
ence sequence, CaPSID identiﬁes unknown reads when
they also do not map to the PRS by testing against an
in-memory indexed copy of LPRS,w h i c hi se x pec t edt obe
relatively small (lines 9 to 13).
Algorithm 1 CapSID’s digital subtraction method
Require: input LPRS -l i s to fr e a d st h a ta l i g nt ot h e
pathogen reference sequence
Require:inputLHRS-listofreadsthataligntothehuman
reference sequence
Require: input LNHRS -l i s to fr e a d st h a td on o ta l i g nt o
the human reference sequence
1: for each item in LPRS do
2: add item to PATHOGENSTORE
3: end for
4: for each item in LHRS do
5: if item in PATHOGENSTORE then
6: add item to HUMANSTORE
7: end if
8: end for
9: for each item in LNHRS do
10: if item is not in LPRS then
11: add item to ﬁle(FASTQ)
12: end if
13: end for
To better evaluate the signiﬁcance of the ﬁndings, the
Analysis Module calculates four diﬀerent metrics for each
sampleandforeachprojectasawhole(deﬁnedasacollec-
tion of samples): (i) the total number of aligned reads (or
hits)acrossanygivenpathogengenome,(ii)thetotalnum-
ber of hits across genes only within a pathogen genome,
(iii) the total coverage across each pathogen genome and
(iv) the maximum coverage across any of the genes in
a given pathogen genome. Here we deﬁne coverage as
the number of genome nucleotides represented in aligned
reads normalized by the genome length. Code that cal-
culates the four metrics for each sample has been par-
allelized to run on multiple processors in order to make
these calculations over samples faster.
In addition to the Genome and Analysis Modules,
CaPSID includes a command-line script for manipulat-
ing FASTQ ﬁles that allows the ﬁltering of low quality
reads and the removal of duplicates before alignment to
reference sequences. The ﬁltering is based on two param-
eters set by the user, the Phred quality threshold and the
number of base pairs allowed below that threshold.
Processing digital subtraction and calculating metrics
on two BAM ﬁles of 34 GB and 31 GB respectively takes
approximately 15 minutes when using 5 GB of RAM on a
16-core AMD 64-bit processor.
The CaPSID Database
One of the main unique features of CaPSID is that ref-
erence sequences and digital subtraction results are both
stored as linked data in MongoDB, a scalable, high-
performance, open source document-oriented database
[17].Borozan etal. BMCBioinformatics 2012, 13:206 Page 4 of 11
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The CaPSID database records information on each
read identiﬁed by the pipeline as part of the two ﬁrst
output sets described above, namely on each read that
aligns to either the PRS alone, or to both the HRS and
the PRS. The stored ﬁelds include, for example, alignment
location, length, score, average base qualities, alignment
sequence, CIGAR(Compact Idiosyncratic Gapped Align-
ment Report) information, number of mismatches and
whether the read aligns to HRS. Storing both genome
and read data makes it possible to run analysis quickly
over known gene locations to determine which reads are
aligning over gene regions. The third output set of reads
identiﬁed by the pipeline (reads which do not align to any
of the reference sequences) is not stored in the database
but is rather saved in FASTQ format to the local ﬁle
system for further processing.
Next generation sequencing produces large amount of
data and because CaPSID stores information about each
aligned read and each reference sequence, it needs to deal
eﬀectively with large data sizes. CaPSID uses MongoDB
[17], a database software that scales horizontally by shard-
ing the database across a cluster of servers, while still
enabling fast retrieval of large volume of data. Thanks
to this scalable architecture, there is virtually no limit as
to how many reads or experiments CaPSID can store in
its database. MongoDB reports [17] examples of highly
accessed production systems with more than 3.5 TB more
than 3.5 TB and over 20 billion records. MongoDB also
provides the safety of having no single point of failure,
as well as distributing both the processing load and data
storage requirements. We tested CaPSID on a single node
with more that 25 million read records from 113 diﬀer-
ent transcriptomes samples without signiﬁcant drop in
its performance. Another advantage of using MongoDB
is that it oﬀers API access to a number of program-
ming languages (such as R, Python, Java and more) which,
depending on users’ needs, allow a broad range of custom
type data analysis.
CaPSID allows also users to store meta-information
about each project (deﬁned as a set of samples) and sam-
ple. For example, the user can specify the type of disease,
the type of cell and sample source together with alignment
information (such as the aligner used, sequencing plat-
form, type of sequencing and the location of BAM ﬁles)
for each sample to be processed.
This database is a key component of the CaPSID plat-
form since it allows users to store, organize and analyze
the relevant information from individual samples (derived
from the BAM ﬁles) in a simple and seamless way, without
the burden of manipulating them programmatically.
The CaPSID Web Application
After digital subtraction, CaPSID’s web interface enables
research attention to be focused on those parts of the
sequencing datasets that match the pathogen reference
sequences. Its aim is to provide researchers with a rich
and interactive interface to manage, query and visual-
ize project results stored in the database. For example, it
allows users to search for a speciﬁc pathogen and view
its statistics across multiple samples or to display sortable
tables of coverage statistics for any sample or project (see
Figure 2). CaPSID also lets users rank genome hits in a
given sample or project by using any of the four metrics
described above. CaPSID integrates the genome browser
JBrowse [18] to allow, in a simple mouse click, visual-
izing and analyzing the distribution of read alignments
from one or many samples of a given pathogen genome
a n di t sg e n e s( s e eF i g u r e3 ) .T h eb r o w s e rc a na l s od i f -
ferentiate between reads that align PRS only and those
that align to both HRS and PRS, allowing users to quickly
see which proportion of reads also align to a reference
sequence.
CaPSID was designed to be used as a platform for
large collaborative projects, such as those between lab-
oratories, and functions as a centralized repository of
information. Separating the interface from the analysis
pipelineiscentraltothis,asitenablesthosewithoutdirect
experienceofhigh-throughputsequencingsystemstopar-
ticipate in expert judgements on the digitally subtracted
sample datasets.
To enable this, projects in CaPSID are deﬁned as a col-
lection of samples and allow for ﬁne-grained control over
user access levels. There are three levels of access to a
project: users, collaborators and owners. Users have read-
only access to projects, collaborators have permission to
add, edit and remove samples and owners have full access
to the project, which includes the ability to give permis-
sion for others users to access the project, and to remove
the project and all associated data entirely from the plat-
form. In addition to speciﬁc user level access, projects on
the platform can be made public, giving all CaPSID users
read-access to the samples.
The CaPSID web application is written in Groovy using
the Grails web framework, and allows user authentica-
tion and authorization data to be deﬁned in the CaPSID
database,anLDAPserveroracombinationofthetwo.For
example, speciﬁc user permissions can be stored in the
CaPSID database, while login credentials come from an
external LDAP server. This gives full project control to the
CaPSID administrators, while still keeping the centralized
access control of an LDAP server.
CaPSID’s manual and documentation
We have provided comprehensive documentation for
installing and using CaPSID, complete with a step by
step tutorial that takes users from creating a project
and loading sequencing data, to analyzing and visual-
izing aligned reads across pathogen genomes. The fullBorozan etal. BMCBioinformatics 2012, 13:206 Page 5 of 11
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Figure 2 Shows sortable tables of coverage statistics for a sample displayed by CaPSID.
documentation is available at https://github.com/capsid/
capsid/wiki.
Results and discussion
Analyzing sequencing data using CaPSID
TestingCaPSIDpipelineaccuracy
In order to assess our pipeline and its eﬃciency to sub-
tracthumansequencesanddetectpathogenones,wehave
created a dataset by combining short read sequences from
a real human transcriptome sample (publicly available
from dbGAP) with sequences simulated at random from
10 viral reference genomes. The publicly available dataset
consists of 9 million single-end reads (with read length of
65 base pairs) sequenced from a normal human tissue. We
found that 97.3% of reads aligned to the human genome
and 0.08% (7241) to viral genomes.
The simulated dataset consisted of 10000 65-mers ran-
domly generated from 10 viral genomes, and 270 reads
known to map to both viral and human genomes. The 270
reads were not simulated but selected from one of our
own sequenced dataset that has been previously aligned
to both the HRS and PRS.
We note that the Novoalign algorithm, before it
attempts to align short reads, ﬁlters those that have low
Figure 3 CaPSID’s integrated genome browser JBrowse. CaPSID’s integrated genome browser JBrowse, displaying the distribution of read
alignments from diﬀerent samples for a given genome (reads aligning simultaneously to the human reference are shown in red).Borozan etal. BMCBioinformatics 2012, 13:206 Page 6 of 11
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quality and low complexity by default. For users who want
to use other short read aligners that do not include ﬁlter-
ing options, CaPSID oﬀers a way of ﬁltering short reads
with low quality prior to the alignment (see the CaPSID’s
pipeline section). Users should choose their ﬁltering crite-
ria with care as too stringent ﬁltering could eliminate too
many reads and produce a drop in sensitivity in detecting
viral genomes.
The two datasets (human and simulated) were com-
bined into one single FASTQ ﬁle and all short reads were
then aligned to the human and viral reference sequences
using Novoalign. The two BAM ﬁles produced from the
alignment step were then processed by CaPSID. CaPSID
correctly identiﬁed all of the 17511 reads that mapped to
viruses (i.e., 7241 from the original human sample and
10270 from the simulated dataset). As explained in the
implementation section, CaPSID also keeps a record of
reads that align to both human and non-human reference
sequences. Our simulated dataset contained 270 of these
reads, and CaPSID correctly identiﬁed all of them as well.
These results demonstrate the accuracy of our pipeline
that is its ability to correctly discriminate all of the align-
ments results provided by the aligner.
It is worth emphasizing, however, that the alignment
accuracy is independent of the CaPSID pipeline and
depends entirely on the choice of the alignment algorithm
and the quality of the sequenced reads.
TheBAMﬁlesfromthissimulateddatasetcanbedown-
loaded from the CaPSID’s homepage as part of its demo
package.
Ovariancancerdataset
Sixteen ovarian tumor transcriptomes were sequenced
(for a total of 2.5 billion of reads) at the Ontario Insti-
tute for Cancer Research using both the Illumina and AB
SOLiD technologies.
Sequenced samples were ﬁrst aligned to human and
pathogen genomes and then processed through CaPSID’s
analysispipeline.Afterrankingallreportedvirusgenomes
in each sample according to the maximum gene cov-
erage metric using CaPSID’s web interface, one sample,
OVCA0016, came to our attention.
Figure 4 shows that in this sample, among its top four
genome hits with gene coverage greater than 90% were
the simian virus 40 (SV40) followed by three group C-
type human adenovirus genomes. Further analysis using
CaPSID’s genome browser revealed that SV40 reads were
concentrated almost entirely across its small and large
T-antigens (Figure 5A) whereas only the early region 1
E1A and E1B adenovirus (most likely Ad5) genes were
expressed (Figure 5B). As it seemed highly unlikely to
ﬁnd a human ovarian tumor expressing both adenovirus
and SV40 oncogene products, we hypothesized if the
OVCA0016 cell line had been contaminated with or
accidentally replaced by 293T cells, an SV40 T antigen-
expressing human embryonic kidney cell line [19] derived
from Ad5 E1A-/E1B-expressing 293 cells [20].
To process the OVCA0016 sample with approx 255 mil-
lion reads in two BAM ﬁles of 22 GB and 30 GB takes
approximately 21 minutes when using 5GB of RAM on a
16-core AMD 64-bit processor.
Invitrovalidation
To examine this possibility OVCA0016 cells as well as
293T (positive control) and human H1299 lung carci-
noma(negativecontrol)cellswereharvestedinlysisbuﬀer
and proteins were separated on SDS-PAGE gels, trans-
ferred onto PVDF membranes and probed for Ad5 E1A
(Figure 6A top panel), Ad5 E1B55K (middle panel), and
SV40 large T (bottom panel), as described previously [21].
With each of these proteins, a signal was detected in
OVCA0016 at intensities similar to those found in 293T
cells, whereas no signal was observed for either in H1299
cells. The same three cell lines were also grown on cover
slips, ﬁxed with 4% paraformaldehyde, stained with the
same antibodies and analysed by immunoﬂuorescence on
a confocal microscopy as described previously [22]. In
each case about 400 cells were analyzed in multiple ﬁelds
for the expression of E1A protein, E1B55K or SV40 T
antigen. Figure 6B shows representative ﬁelds examined
and that in the case of 293T cells, every cell observed
expressedallthreeviralproteinswhereaswithH1299cells
none of these species was observed in any cell. Interest-
ingly, with OVCA0016, all cells examined appeared to
express both Ad5 E1A and E1B; however, in the case
of SV40 T antigen, only one ﬁeld of all cells examined
contained any cells that failed to express this viral pro-
tein (marked in the Figure 6B with arrows). As 293T
Figure 4 The top four pathogen genomes hit in the 293T cells as calculated by CaPSID. The top four genomes hit with the maximum
coverage greater than 90% ranked by their maximum gene coverage.Borozan etal. BMCBioinformatics 2012, 13:206 Page 7 of 11
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Figure 5 The distribution of aligned reads across top four pathogen genomes hit in the OVCA0016 cells. A- Shows the distribution of hits
across the SV40 viral genome, with aligned reads concentrating almost entirely across its small and large T-antigens. B- Shows E1A and E1B genes to
be expressed in all three adenoviruses.Borozan etal. BMCBioinformatics 2012, 13:206 Page 8 of 11
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Figure 6 Analysis of adenovirus E1A/E1B and SV40 T antigen expression in OVCA0016 cultures. A - Western blotting analysis. Extracts from
OVCA0016, 292T and H1299 cells were analyzed by western blotting using M73 (E1A), 2A6 (E1B55K) and Pab101 (SV40 T antigen, BD Pharmingen)
antibodies, as described previously [21]. B - Immunoﬂuorescence microscopy. The same cells types were grown on coverslips and analyzed by
confocal immunoﬂuorescence microscopy [22]. Cells not expressing T antigen have been indicated with arrows on the ﬁgure.
cells are known to multiply in clumps, these results sug-
gested that at most only 1-2% of cells failed to express
these viral proteins, suggesting that the OVCA0016 cell
line may indeed have been accidentally contaminated and
eventually largely overgrown by 293T cells. This hypoth-
esis was then conﬁrmed by interrogation of the DSMZ
STR database [23] using 9 short tandem repeat (STR)
sequences of OVCA0016 cells generated at the The Cen-
tre for Applied Genomics (TCAG). The table provided
(see Additional ﬁle 1) shows that the top 10 results
with the highest arbitrary evaluation value (EV) are 293T
and other corresponding variants (HKb20, ProPak-X.36,
ProPak-A.52...).
These results indicated that indeed the OVCA0016 cell
line appeared to consist almost entirely of 293T cells, with
only a small percentage of the original tumor cell line
remaining.
Although these results are of no biological signiﬁcance,
this unfortunate contamination of the OVCA0016 ovar-
ian tumor cell line by 293T cells oﬀered an ideal blind test
of the eﬃcacy of CaPSID and demonstrated its ability to
detect viral gene expression in transcriptome sequences
from human tumor cell lines.
Assemblyoftheunalignedreads
As mentioned earlier, CaPSID saves after digital subtrac-
tion, the reads that do not align to any of the refer-
ences sequences in a FASTQ ﬁle. The existence of these
unaligned reads could be indicative of the presence of
some unknown pathogen (or organism) in the sequenced
sample. In order to further characterize the unaligned
reads in the contaminated sample, we performed de novo
assembly of unmapped reads using the short-read assem-
bler Trinity [24].
We note that when assembling whole genome sequenc-
ing data (WGS), where the result of alternative splicing
is not observed, users should choose a diﬀerent assembly
algorithm such as Velvet [25]. Of the total of 255 million
reads, 9 million did not map to any reference sequence
in the CaPSID’s database, of these approximately 7.69%Borozan etal. BMCBioinformatics 2012, 13:206 Page 9 of 11
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assembled into contigs. The Trinity assembler produced
in total 13395 contigs ranging from 201 to 6483 bp in
length. Using BLAT [26] and MEGA-BLAST [27], we
found that only 69 of the assembled contigs did not
map to any of the sequences present in either CaPSID’s
or NCBI’s reference databases. In order to identify pos-
sible novel pathogens, these 69 contigs were screened
for the presence of known protein features, using the
InterPro [28] database of protein families, domains and
functional sites. Nucleic acid sequences were ﬁrst trans-
lated in all 6 frames and then scanned using the Inter-
ProScan (iprscan soappy.py –crc –goterms). We found
that none of them displayed a protein feature similar
to the pathogen protein features found in the Inter-
Pro database. We conclude that none of the remaining
contigs are derived from a known pathogen and more
likely are due to either sequencing artifacts, unchar-
acterized regions of the human genome or the pres-
ence of some unknown organism having protein fea-
tures that do not match any of the protein motifs in the
InterPro database.
The comparison of CaPSID to other software for the
identiﬁcationofpathogensinhigh-throughputsequencing
As mentioned in the background section a number of
computational approaches already exist [4-9] for the dis-
covery and detection of known and new pathogens from
high-throughput sequencing data. However only two of
these, namely PathSeq [6] and RINS [9], are available as
integrated open source software similar to CaPSID.
Speciﬁcityandsensitivityanalysiscomparison
In this section we compare the accuracy and sensitivity
of CaPSID to that of RINS [9], a recently published soft-
ware for the identiﬁcation of non-human sequences in
high-throughput sequencing datasets.
In order to compare results obtained with CaPSID and
RINS we have created a benchmark dataset composed
entirely of simulated reads drawn at random from both
the human and viral reference sequences. The bench-
mark dataset is composed of 10 million reads (read length
of 100 bp) generated at random from the human refer-
ence sequence (GRCh37/hg19) spiked with 10000 reads
(read length of 100 bp) generated at random from 10 viral
genomes. Each viral genome was then mutated by ran-
dom substitutions at 3 distinct rates (5%, 10% and 25%).
One thousand reads from each mutated genome were
then randomly generated to produce an additional 30000
viral reads (1000×10×3). Since the read composition of
the benchmark dataset is exactly known it serves as a
good standard for evaluating the accuracy and sensitiv-
ity of both CaPSID and RINS. In the CaPSID analysis all
reads from the benchmark dataset were aligned with the
freely available Bowtie 2 [15] aligner. The three metrics
used to compare the two software applications are deﬁned
in eqs.(1-3) as shown below.
Sensitivity =
nvgNOT
nvgTot
(1)
Speciﬁcity =
nhg
nhgTot
(2)
and the average hit rate (hit rate)a s
hit rate(in%) =
1
10
·
10 
g=1
nvgTRUEg
nvgTotg
(3)
where nvgNOT, nvgTot, nhg, nhgTot, nvgTRUEg and nvgTotg are
deﬁned as shown below
nvgNOT = # of reads derived from viral genomes
mapping to the human reference
nvgTot =t o t a l# of reads derived from viral genomes
nhg = # of reads derived from the human genome
mapping to the human reference
nhgTot =t o t a l# of reads derived from the human
genome
nvgTRUEg = # of reads derived from the viral genome g
mapping to the viral reference sequence g
nvgTotg =t o t a l# of reads derived from the viral
genome g
We found that the sensitivity and speciﬁcity of both
CaPSID and RINS were 100% on the benchmark dataset
(including both the non-mutated and mutated data). The
results of our analysis indicate that CaPSID gives very
similar results to those of RINS in terms of sensitiv-
ity, speciﬁcity and performance (CaPSID runs in < 20
min and RINS in < 14 min when performing the anal-
ysis on the benchmark dataset containing ≈ 10 million
reads on a 16-core AMD 64-bit processor using < 6GB
or RAM). However when using our third metric (see
eq.3) we ﬁnd that CaPSID performs better than RINS by
mapping signiﬁcantly more reads derived from mutated
genomes back to their original reference sequences as
shown in Table 1. This result demonstrates the ability of
our approach to identify viral genomes with substantially
divergentsequences(upto25%)andindicatesthatitcould
be used for the identiﬁcation of novel pathogen with up
to 25% homology to the reference sequences stored in its
database.
Otherfeaturecomparison
In addition to the comparison in accuracy and per-
formance presented above, CaPSID includes additional
important features that to the best of our knowledge are
not part of either PathSeq or RINS.
• Unlike PathSeq or RINS, which are primarily analysis
tools, CaPSID has an easy to use and manageableBorozan etal. BMCBioinformatics 2012, 13:206 Page 10 of 11
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Table 1 Comparison of the average hit rate between CaPSID and RINS for the three distinct mutation rates
0% 5% 10% 25%
hit rate(CaPSID) 100% 95.51% 65.39% 1.11%
hit rate(RINS) 100% 66.21% 19.60% 0.20%
database allowing users to organize, store, analyze
and visualize information from each project and
sample in a seamless way. CaPSID’s database is
accessible by CaPSID’s user-friendly web application
that integrates a genome browser (complete with
genome annotations) making the analysis and
visualization of alignment results straightforward.
• CaPSID provides coverage metrics that allow users to
rank pathogens in signiﬁcance based not only the
overall genome coverage but on the gene coverage as
well.
• In CaPSID, users can align short reads using any
aligner of their choice: having a single preferred
aligner might be a limiting factor especially as new
faster and more accurate aligners become available
(for example PathSeq uses the MAQ aligner followed
by Mega BLAST and BLASTN in order to align those
reads with additional mismatches or gaps that are not
aligned by MAQ (see [6]) and RINS [9] uses a
combination of BLAT and Bowtie).
• Unlike PathSeq or RINS, CaPSID does not wholly
remove reads that simultaneously map to both
human and pathogen genomes but keeps them in the
database allowing rapid identiﬁcation of
pathogen-to-host integration sites.
• CaPSID does not require a third party commercial
computing platform such as the one used by PathSeq
(Amazon Elastic Compute Cloud, EC2) and can be
run eﬃciently on either a desktop computer or a
cluster.
PathSeq performs subtractive alignments using six dif-
ferent human genomes and then uses local aligners such
as Mega BLAST and BLASTN to re-align reads (not
aligned by MAQ during the initial alignments) to the
two additional human sequence databases. In compari-
son, CaPSID’s current subtraction is done in one pass
against a single human reference genome with splice junc-
tions. Thus CaPSID might potentially fail to subtract
some of the reads aligned by PathSeq to its database
of human references– although this is not a fundamen-
tal constraint of the CaPSID architecture, and further
work to use multiple human reference databases would
be relatively straightforward. However, because PathSeq
uses local aligners its approach can be computationally
very intensive and for users desiring to identify known
pathogens with a large reduction in runtime CaPSID’s
approach might be more advantageous, especially when
handling the large datasets of next generation sequenc-
ing.Inaddition,CaPSID’sthree-wayapproachofretaining
reads that map to pathogen genomes, even when they also
map to human genomes, reduces the risk that pathogen
reads are inadvertently omitted during subtraction by
both PathSeq or RINS.
Conclusions
In this article, we have presented CaPSID– a comprehen-
sive bioinformatics platform for the detection of pathogen
sequences in genome and transcriptome samples. We
have demonstrated that CaPSID is an eﬃcient tool that
performs well on both the simulated and real datasets. We
have shown that CaPSID’s predictions can be successfully
validated in vitro, and that CaPSID oﬀers new and useful
features that arenotavailableinanycurrent softwareused
for the identiﬁcation of pathogens in high-throughput
sequencing. Furthermore and more importantly, CaPSID
is suitable for collaborative types of projects between
teams of scientists, for example between bioinformati-
cians and molecular virologists, through its web interface
allowing researchers without expert knowledge in com-
putational techniques to analyze alignment results stored
in the CaPSID’s database. The CaPSID platform is cur-
rently used in real production environment to analyze
sequencing data generated by the OICR laboratories from
diﬀerent tumor types. Since CaPSID was deployed at the
OICR, it was used in the analysis of more than 113 tran-
scriptomesamplesacrosssixdiﬀerentprojectswithatotal
of 25 million aligned reads stored in the CaPSID database.
W eb e l i e v eC a P S I Dt ob eav e r s a t i l er e s e a r c ht o o lt h a tw e
hope will be used by researchers for the detection and
identiﬁcation of known and new pathogens using next
generation sequencing data.
Availability and requirements
Project Name: CaPSID
Project home page: https://github.com/capsid/capsid
Operating system(s): Linux, Mac OS X
Programming language: Python 2.7 (no support for
Python 3 at the moment), Groovy
Other requirements: MongoDB, OpenJDK (≥ 1.6.0 20),
BioPython
License: GNU GPL3
Any restrictions to use by non-academics: NoneBorozan etal. BMCBioinformatics 2012, 13:206 Page 11 of 11
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Additional ﬁle
Additional ﬁle 1: Table S1. Short tandem repeat sequence (STR) analysis
in OVCA0016. Table S1 shows that the top 10 results with the highest
arbitrary evaluation value (EV) are 293T and other corresponding variants
(HKb20, ProPak-X.36, ProPak-A.52...).
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